CBS 2019
CBSMD教育中心
English

ASCVD Prevention

科研文章

荐读文献

Cardiovascular risk prediction in type 2 diabetes: a comparison of 22 risk scores in primary care settings 2019 Guidelines on Diabetes, Pre-Diabetes and Cardiovascular Diseases developed in collaboration with the EASD ESC Clinical Practice Guidelines Active factor XI is associated with the risk of cardiovascular events in stable coronary artery disease patients Potential Mechanisms of In-stent Neointimal Atherosclerotic Plaque Formation International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association Relationship Between Coronary Artery Calcium and Atherosclerosis Progression Among Patients With Suspected Coronary Artery Disease Non-obstructive High-Risk Plaques Increase the Risk of Future Culprit Lesions Comparable to Obstructive Plaques Without High-Risk Features: The ICONIC Study Effect of the PCSK9 Inhibitor Evolocumab on Total Cardiovascular Events in Patients With Cardiovascular DiseaseA Prespecified Analysis From the FOURIER Trial Effects of empagliflozin on first and recurrent clinical events in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a secondary analysis of the EMPA-REG OUTCOME trial

Original Research2019 Jan 15. [Epub ahead of print]

JOURNAL:EuroIntervention. Article Link

The Prevalence of Myocardial Bridging Associated with Coronary Endothelial Dysfunction in Patients with Chest Pain and Non-Obstructive Coronary Artery Disease

Sara JDS, Corban MT, Prasad M et al. Keywords: myocardial bridging; prevalence; coronary endothelial dysfunction; chest pain; angina; non obstructive CAD

ABSTRACT

AIMS - Myocardial bridging (MB), characterized by the epicardial coronary vessel diving into the myocardium, is present up to 1/3rd of adults and is associated with accelerated atherosclerosis, and angina. In the current study we determine the association between MB and coronary endothelial dysfunction.


METHODS AND RESULTS - Patients with chest pain and nonobstructive CAD (stenosis < 40%) at angiography underwent invasive assessment of endothelial function. Epicardial endothelial function was assessed by measuring the percent change in coronary artery diameter in response to intracoronary infusions of acetylcholine (%ΔCADAch). Epicardial endothelial dysfunction was defined as %ΔCADAch of < -20%. Microvascular endothelial function was assessed as the percent change in coronary blood flow in response to intracoronary infusions of acetylcholine (%ΔCBFAch), and microvascular endothelial dysfunction was defined as %ΔCBFAch of < 50%. MB was diagnosed angiographically. The frequency of epicardial and microvascular endothelial dysfunction was compared between patients with and without MB. Results Between 1993 and 2012, 1,469 patients (mean age 50.4 years, 35% male) underwent coronary angiography and invasive testing of endothelial function. Two hundred eight (14.2%) patients had MB. Patients with MB had a higher frequency of epicardial endothelial dysfunction compared to patients without MB. In multivariate analyses, MB was a significant predictor of epicardial (OR, 95% CI, 1.45, 1.05 - 2.01, p=0.026) and microvascular endothelial dysfunction (OR, 95% CI, 1.36, 1.00 - 1.85, p=0.047).


CONCLUSIONS - MB is significantly associated with epicardial and microvascular endothelial dysfunction in patients with non-obstructive CAD supporting its potential role as a mechanism for angina in symptomatic patients with MB.